Literature DB >> 20980578

Temporal characterization of carrot broth-enhanced real-time PCR as an alternative means for rapid detection of Streptococcus agalactiae from prenatal anorectal and vaginal screenings.

Erik Munson1, Maureen Napierala, Kimber L Munson, Anne Culver, Jeanne E Hryciuk.   

Abstract

Analysis of overnight carrot broth culture using the BD GeneOhm StrepB assay (carrot broth-enhanced PCR) yields increased sensitivity compared to that of carrot broth culture alone for the detection of Streptococcus agalactiae. We investigated the prospect of reducing the carrot broth incubation time prior to PCR performance. In vitro experimentation demonstrated that carrot broth-enhanced PCR nominally detected 10 CFU S. agalactiae after 4 h of carrot broth incubation with competitive flora. Detection rates improved with inocula of 100 and 1,000 CFU S. agalactiae, with the majority of these aliquots demonstrating detection after 2 h of carrot broth incubation. Carrot broth was prospectively inoculated with clinical vaginal/anorectal swabs, with 500-μl aliquots collected. Early aliquots from 227 specimens were subjected to carrot broth-enhanced PCR (early-aliquot carrot broth-enhanced PCR) in instances of subsequent positive carrot broth culture or positive overnight clinical carrot broth-enhanced PCR. The S. agalactiae detection rate by early-aliquot carrot broth-enhanced PCR (66.1%) exceeded that observed for 227 remnant swabs retrospectively tested by direct swab PCR (56.4%; P=0.03). Early-aliquot carrot broth-enhanced PCR detection rate differences were most pronounced in aliquots from 83 carrot broth aliquots collected after 6 h (84.3%) compared to detection rates from either direct swab PCR of these samples (51.8%; P<0.0002) or early-aliquot carrot broth-enhanced PCR of 144 carrot broth aliquots collected after fewer than 6 h of incubation (55.6%; P<0.0002). Enhanced sensitivity of early-aliquot carrot broth-enhanced PCR versus direct swab PCR suggests that this assay could serve as a surrogate rapid detection method facilitating the prevention of group B streptococcal disease.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20980578      PMCID: PMC3008479          DOI: 10.1128/JCM.01734-10

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  34 in total

1.  Rapid detection of group B streptococci in pregnant women at delivery.

Authors:  M G Bergeron; D Ke; C Ménard; F J Picard; M Gagnon; M Bernier; M Ouellette; P H Roy; S Marcoux; W D Fraser
Journal:  N Engl J Med       Date:  2000-07-20       Impact factor: 91.245

2.  Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis.

Authors:  S J Schrag; S Zywicki; M M Farley; A L Reingold; L H Harrison; L B Lefkowitz; J L Hadler; R Danila; P R Cieslak; A Schuchat
Journal:  N Engl J Med       Date:  2000-01-06       Impact factor: 91.245

3.  Selective intrapartum chemoprophylaxis of neonatal group B streptococcal early-onset disease. I. Epidemiologic rationale.

Authors:  K M Boyer; C A Gadzala; L I Burd; D E Fisher; J B Paton; S P Gotoff
Journal:  J Infect Dis       Date:  1983-11       Impact factor: 5.226

4.  Group B streptococcal colonization and serotype-specific immunity in pregnant women at delivery.

Authors:  J R Campbell; S L Hillier; M A Krohn; P Ferrieri; D F Zaleznik; C J Baker
Journal:  Obstet Gynecol       Date:  2000-10       Impact factor: 7.661

5.  Prenatal screening for infectious diseases and opportunities for prevention.

Authors:  Stephanie J Schrag; Kathryn E Arnold; Janet C Mohle-Boetani; Ruth Lynfield; Elizabeth R Zell; Karen Stefonek; Heather Noga; Allen S Craig; Laurie Thomson Sanza; Glenda Smith; Anne Schuchat
Journal:  Obstet Gynecol       Date:  2003-10       Impact factor: 7.661

6.  A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates.

Authors:  Stephanie J Schrag; Elizabeth R Zell; Ruth Lynfield; Aaron Roome; Kathryn E Arnold; Allen S Craig; Lee H Harrison; Arthur Reingold; Karen Stefonek; Glenda Smith; Melanie Gamble; Anne Schuchat
Journal:  N Engl J Med       Date:  2002-07-25       Impact factor: 91.245

7.  Diminishing racial disparities in early-onset neonatal group B streptococcal disease--United States, 2000-2003.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2004-06-18       Impact factor: 17.586

8.  Evaluation of three commercial broth media for pigment detection and identification of a group B Streptococcus (Streptococcus agalactiae).

Authors:  Maria da Glória Carvalho; Richard Facklam; Delois Jackson; Bernard Beall; Lesley McGee
Journal:  J Clin Microbiol       Date:  2009-10-07       Impact factor: 5.948

9.  Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC.

Authors:  Stephanie Schrag; Rachel Gorwitz; Kristi Fultz-Butts; Anne Schuchat
Journal:  MMWR Recomm Rep       Date:  2002-08-16

10.  Selective intrapartum chemoprophylaxis of neonatal group B streptococcal early-onset disease. II. Predictive value of prenatal cultures.

Authors:  K M Boyer; C A Gadzala; P D Kelly; L I Burd; S P Gotoff
Journal:  J Infect Dis       Date:  1983-11       Impact factor: 5.226

View more
  4 in total

1.  Evaluation of StrepBSelect Chromogenic Medium and the Fast-Track Diagnostics Group B Streptococcus (GBS) Real-Time PCR Assay Compared to Routine Culture for Detection of GBS during Antepartum Screening.

Authors:  Deirdre L Church; Heather Baxter; Tracie Lloyd; Oscar Larios; Daniel B Gregson
Journal:  J Clin Microbiol       Date:  2017-04-26       Impact factor: 5.948

2.  Antepartum screening for group B Streptococcus by three FDA-cleared molecular tests and effect of shortened enrichment culture on molecular detection rates.

Authors:  Brianne A Couturier; Trent Weight; Haley Elmer; Robert Schlaberg
Journal:  J Clin Microbiol       Date:  2014-07-09       Impact factor: 5.948

3.  Comparison of the AmpliVue, BD Max System, and illumigene Molecular Assays for Detection of Group B Streptococcus in Antenatal Screening Specimens.

Authors:  Shelley A Miller; Eszter Deak; Romney Humphries
Journal:  J Clin Microbiol       Date:  2015-03-18       Impact factor: 5.948

4.  Evaluation of Trans-Vag broth, colistin-nalidixic agar, and CHROMagar StrepB for detection of group B Streptococcus in vaginal and rectal swabs from pregnant women in South Africa.

Authors:  Gaurav Kwatra; Shabir A Madhi; Clare L Cutland; Eckhart J Buchmann; Peter V Adrian
Journal:  J Clin Microbiol       Date:  2013-05-22       Impact factor: 5.948

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.